Invalidity dossier
US 9055868
System and method for voice control of medical devices
Current assignee: Omni Medsci Inc
Added 5/14/2026, 6:00:49 AM
Active provider: Google · gemini-2.5-flash
Auto-generating section 1 of 1: Derivative works…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
Patent summary
Title, assignee, inventors, filing/issue dates, abstract, and a plain-language overview of the claims.
US Patent 9055868, titled "System and method for voice control of medical devices," was invented by Mohammed N. Islam. The patent was filed on September 3, 2014, and issued on June 16, 2015. The current assignee is Omni Medsci Inc., as of October 16, 2024, following previous reassignments to Omni Continuum, LLC and Cheetah Omni LLC.
Abstract:
A diagnostic system is described that includes semiconductor diodes, a multiplexer, and waveguide structures to create an output light beam. A lens system directs this beam onto a user's body part containing blood for measurement. A software application processes the measurement data to generate physiological information, operating on a control system that may feature a touchscreen, proximity sensor, and wireless transceiver for transmitting data. A host system receives and stores this wireless data, processes it with control logic (including voice recognition software in some embodiments) to determine the user's status, records the status, and outputs it to one or more remote display devices.
Plain-Language Overview of Independent Claims:
Claim 1: This claim describes a diagnostic system that uses multiple semiconductor diodes as a light source. These light beams are combined by a multiplexer into one or more wavelengths, which are then transmitted through a waveguide to create an output beam. A lens system directs this beam onto a patient's blood-containing body part for measurement. A software application processes this measurement to generate physiological information, running on a control system that can receive voice and manual inputs, and includes a touchscreen, proximity sensor, and wireless transceiver. A host system receives, stores, and processes this wireless data to determine the user's status, records it, and communicates it to remote displays.
Claim 10: This claim focuses on a diagnostic system with a light source of one or more semiconductor diodes. A lens system directs the input light beam onto a patient's blood-containing body part for a measurement. A software application generates physiological information from this measurement and operates on a control system with a touchscreen, location sensor circuitry, and a wireless transceiver. This control system also accepts voice and manual inputs. A host system stores and processes the wireless data to generate a user's status, records it, and sends it to remote displays.
Claim 19: This claim details a diagnostic system similar to Claim 10, but specifically states that the measurement performed on the user's blood involves a spectroscopic procedure to measure a blood property. This procedure is based on comparing the amplitudes of transmitted or reflected light at multiple wavelengths. Additionally, the control system is coupled to an audio output device, and the host's control logic specifically includes voice recognition software to process voice input signals.
Claim 28: This claim covers a light-based medical diagnostic system that uses a pump source with multiple semiconductor diodes and a multiplexer to create a multiplexed pump beam with one or more wavelengths. This beam enters a first waveguide (which includes a gain fiber) to produce a first optical beam. A second waveguide receives this first optical beam and communicates it to an output end, forming an output beam with at least one wavelength of 1.7 microns or more. A lens system directs this output beam through a patient's mouth onto their blood. This output beam is specifically for medical diagnostics to measure a blood property, using a differential spectroscopic procedure based on comparing amplitudes at multiple wavelengths.
Claim 37: This claim describes a light-based diagnostic system with a pump source using multiple semiconductor diodes and a multiplexer to generate a multiplexed pump beam. It includes first and second waveguide structures and a lens system. The first waveguide contains a fused silica fiber and outputs a first optical beam. The second waveguide receives this beam and directs it to an output end to form an output beam. The lens system directs a portion of the output beam through a patient's body orifice. This output beam is for multi-wavelength diagnostics to measure a property of the patient's body, using a differential spectroscopic procedure based on comparing amplitudes at multiple wavelengths.
Claim 46: This claim outlines a light-based medical diagnostic system featuring a pump source with multiple semiconductor diodes and a multiplexer to produce a multiplexed pump beam. A first waveguide, containing a fused silica fiber, receives a portion of this beam and outputs a first optical beam. A second waveguide receives the first optical beam and directs it to an output end to form an output beam. A lens system then communicates a portion of this output beam onto a part of the patient's body containing blood.
Claim 55: This claim defines a medical device with an insertable portion designed to enter a patient's body orifice. This insertable portion has an automated head unit that can be manipulated along at least two axes of motion based on control signals. One or more controllers are coupled to the automated head unit and generate these control signals based on an input signal.
Claim 56: This claim details a medical device aimed at minimizing tissue damage. It includes an insertable portion for insertion into a patient's body orifice, and one or more sensors coupled to this portion. These sensors generate a feedback signal used to substantially minimize damage to the patient's tissue.
Claim 57: This claim describes a medical device for use in a medical procedure, comprising a pump laser that generates a pump signal. A Raman wavelength shifter is coupled to the pump laser and includes a waveguide structure. This Raman wavelength shifter generates an output optical signal with a wavelength of approximately 1.7 microns or more.
Claim 58: This claim specifies a medical device for a medical procedure that includes a Raman wavelength shifter. This shifter is operable to generate an optical signal in the mid-infrared wavelength range, and at least a portion of the Raman wavelength shifter comprises a chalcogenide waveguide.
Claim 59: This claim describes a system for controlling a medical device. It includes a monitor to display medical information to a user and a communication device that receives input signals from the user, which are based on the displayed medical information. One or more processors are coupled to the communication device and convert these input signals into control signals used to manipulate a medical device.
USPTO and CAFC 2026 Dockets:
A search for US patent 9055868 on Google Patents (which often integrates USPTO data) shows its legal status as "Expired - Lifetime" with an anticipated expiration date of August 29, 2023.
Regarding litigation, the patent has a history of cases:
- US case filed in Texas Western District Court (6:23-cv-00478).
- PTAB case IPR2025-01249 filed (Not Instituted - Procedural).
- First worldwide family litigation filed.
- US case filed in Texas Eastern District Court (2:26-cv-00289).
- US case filed in Texas Eastern District Court (2:24-cv-01070).
- US case filed in Delaware District Court (1:25-cv-00140).
Specifically for CAFC 2026 dockets, the provided patent information does not directly list any cases currently active or filed in the CAFC in 2026. However, the listed IPR2025-01249 case from the PTAB could potentially lead to a CAFC appeal in 2026, though its status is "Not Instituted - Procedural". The provided information only shows district court cases and one PTAB case, but no direct CAFC dockets for 2026 for this specific patent. Based on the provided information, there is no authoritative information explicitly stating a CAFC 2026 docket for US9055868.## US Patent 9055868: System and Method for Voice Control of Medical Devices
Title: System and method for voice control of medical devices
Assignee: Omni Medsci Inc. (as of October 16, 2024)
Inventor: Mohammed N. Islam
Filing Date: September 3, 2014
Issue Date: June 16, 2015
Abstract:
US Patent 9055868 describes a diagnostic system that employs a light source with semiconductor diodes and a multiplexer to generate a multiplexed light beam. This beam is transmitted through waveguide structures to create an output beam. A lens system directs this output beam onto a part of a user's body containing blood to perform measurements. A software application processes these measurements to generate physiological information, operating on a control system equipped with a touchscreen, proximity sensor, and a wireless transceiver for data transmission. A host system receives, stores, and processes the wireless data using control logic (which may include voice recognition software) to determine the user's status, record it, and communicate this information to one or more remote display devices.
Plain-Language Overview of Independent Claims:
Claim 1: This claim describes a diagnostic system that uses multiple semiconductor light sources combined by a multiplexer. The combined light travels through waveguides to form an output beam. A lens system focuses this beam onto a patient's body part with blood for a measurement. A software application processes this measurement into physiological data, running on a control system that has a touchscreen, proximity sensor, wireless communication, and can receive both voice and manual inputs. A separate host computer receives this data wirelessly, processes it to determine the patient's status, stores this status, and sends it to remote display screens.
Claim 10: This claim covers a diagnostic system featuring a light source with one or more semiconductor diodes. A lens system directs this light beam onto a patient's blood-containing body part for a measurement. A software application uses this measurement to generate physiological information, running on a control system that includes a touchscreen, circuitry for getting location data from a sensor, and a wireless transceiver for sending data. This control system is also configured to receive voice and manual inputs. A host computer receives and stores the wireless data, processes it to generate the patient's status, records this status, and communicates it to remote display devices.
Claim 19: Similar to Claim 10, this diagnostic system uses one or more semiconductor diodes as a light source. A lens system directs the light onto a patient's blood for a measurement, specifically employing a spectroscopic procedure to measure a blood property. This spectroscopic procedure compares light amplitudes at various wavelengths that are transmitted or reflected from the blood. A software application processes this data into physiological information, running on a control system with a touchscreen, location sensor circuitry, wireless communication, and capabilities for voice and manual input. Notably, this control system is connected to an audio output device, and the host computer's control logic includes voice recognition software to process voice commands.
Claim 28: This claim describes a light-based medical diagnostic system. It includes a pump source with multiple semiconductor diodes that generate pump beams, which are then combined by a multiplexer into a multiplexed pump beam. This beam enters a first waveguide (containing a gain fiber) to produce a first optical beam. A second waveguide receives this first beam and guides it to an output end, creating an output beam with a wavelength of 1.7 microns or more. A lens system directs this output beam through a patient's mouth onto their blood. This system is designed for medical diagnostics, measuring a blood property using a differential spectroscopic procedure that compares light amplitudes at multiple wavelengths reflected or transmitted from the blood.
Claim 37: This claim covers another light-based diagnostic system with a pump source using multiple semiconductor diodes and a multiplexer to create a multiplexed pump beam. It involves a first waveguide (made partly of fused silica fiber) that outputs a first optical beam, and a second waveguide that receives this beam and forms an output beam. A lens system directs a portion of this output beam through an orifice in a patient's body. This system is intended for multi-wavelength diagnostics to measure a property of the patient's body, utilizing a differential spectroscopic procedure that compares light amplitudes at various wavelengths transmitted or reflected from the body part.
Claim 46: This claim outlines a light-based medical diagnostic system that includes a pump source with multiple semiconductor diodes and a multiplexer to combine their pump beams into a multiplexed pump beam. A first waveguide, which contains a fused silica fiber, receives a portion of this multiplexed beam and outputs a first optical beam. A second waveguide then receives this first optical beam and transmits it to an output end to form an output beam. Finally, a lens system directs a portion of this output beam onto a part of a patient's body containing blood.
Claim 55: This claim describes a medical device with an insertable portion that can be placed into a patient's body orifice. This insertable portion includes an automated head unit that can be moved in at least two directions (axes of motion) based on control signals. The device also has one or more controllers connected to this automated head unit, which generate the control signals in response to an input signal.
Claim 56: This claim pertains to a medical device designed to minimize tissue damage. It comprises an insertable portion for entering a patient's body orifice. Coupled to this insertable portion are one or more sensors. These sensors generate a feedback signal that is used to significantly reduce damage to the patient's tissue.
Claim 57: This claim describes a medical device used in a medical procedure. It includes a pump laser that generates a pump signal, and a Raman wavelength shifter connected to the pump laser. At least part of this wavelength shifter is a waveguide structure. The Raman wavelength shifter generates an output optical signal with a wavelength of approximately 1.7 microns or more.
Claim 58: This claim details a medical device for use in a medical procedure, which contains a Raman wavelength shifter. This shifter is capable of generating an optical signal in the mid-infrared wavelength range, and a portion of this Raman wavelength shifter is made of a chalcogenide waveguide.
Claim 59: This claim describes a system for controlling a medical device. It consists of a monitor that displays medical information to a user and a communication device that receives input signals from the user (these signals being based on the information shown on the monitor). One or more processors are connected to the communication device and convert the input signals into control signals that can manipulate a medical device.
USPTO and CAFC 2026 Dockets:
US Patent 9055868 is marked as "Expired - Lifetime" with an anticipated expiration date of August 29, 2023.
The patent has been involved in several litigation cases:
- A US case filed in the Texas Western District Court (case number 6:23-cv-00478).
- A PTAB case, IPR2025-01249, which was filed but procedurally "Not Instituted."
- It is also noted to have had its "First worldwide family litigation filed."
- Other US cases filed in 2024 and 2025 include: Texas Eastern District Court (2:26-cv-00289), Texas Eastern District Court (2:24-cv-01070), and Delaware District Court (1:25-cv-00140).
As of April 26, 2026, there is no authoritative information explicitly detailing any active dockets for US Patent 9055868 at the United States Court of Appeals for the Federal Circuit (CAFC) in 2026. While the PTAB case (IPR2025-01249) could potentially lead to a CAFC appeal, its current status of "Not Instituted - Procedural" does not indicate an active appeal at the CAFC.
Generated 5/21/2026, 12:47:26 PM